Precision Biomarker for Parkinson’s and Lewy Body Dementia Found

Summary: An international consortium discovered a breakthrough quantitative biomarker in cerebrospinal fluid (CSF) that significantly improves the diagnostic accuracy for Parkinson’s disease and Lewy body dementia (LBD). The study identifies…